FREE INVESTOR WEBINAR
Last Chance to Invest In Innovation
There has been very little innovation in surgical drill and distal radius plating systems. Surgeons have to rely on outdated and unsophisticated tools and implant technologies.
At McGinley Orthopedics, we aim to utilize innovative engineering to improve patient outcomes while reducing costs.
It is becoming increasingly rare to find industries untouched by advancement and ripe for the explosive growth that often comes from the introduction of a game-changing technology. Yet, somehow in this era of groundbreaking medical progress, orthopedic tools and plates have remained the same for decades.
With five FDA-cleared products on market and six additional products in active development, McGinley Orthopedics aims to disrupt the orthopedics industry while changing the standard of care and offering returns to their investors.
The standard of care being used in the operating room hasn’t been updated in decades. Surgeons rely on unsophisticated power tools and plates and a sense of “feel” when performing orthopedic surgeries.
This can result in errors that can be dangerous, lead to long-term patient suffering, and are costly for hospitals and surgeons alike. McGinley Orthopedics is on a mission to change that.
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. REGULATION A OFFERINGS ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
McGinley Orthopaedic Innovations is offering securities through the use of an Offering Statement that the Securities and Exchange Commission (‘SEC”) has qualified under Tier II of Regulation A. While the SEC staff reviews certain forms and filings for compliance with disclosure obligations, the SEC does not evaluate the merits of any offering, nor does it determine if any securities offered are “good” investments.
Rialto Markets LLC (“Rialto”) is registered with the Securities and Exchange Commission (“SEC”) as a broker-dealer, member of Financial Industry Regulatory Authority, Inc. (“FINRA”) and Securities Investor Protection Corporation (“SIPC”) and is the broker-dealer of record on this issuer direct offering.
This profile may contain forward-looking statements and information relating to, among other things, the company, its business plan and strategy, and its markets or industry. These statements reflect management’s current views regarding future events based on available information and are subject to risks and uncertainties that could cause the company’s actual results to differ materially. Investors are cautioned not to place undue reliance on these forward-looking statements as they are
meant for illustrative purposes, and they do not represent guarantees of future results, levels of activity, performance, or achievements, all of which cannot be made. Moreover, although management believes that the expectations reflected in the forward-looking statements are reasonable, neither McGinley Orthopaedic Innovations nor anyone acting on its behalf can give any assurance that such expectations will prove to have been correct nor do they have a duty to update any such statements to conform them to actual results.